Previous 10 | Next 10 |
2024-02-23 08:31:06 ET DENVER, Colo., Feb 23, 2024 (www.247marketnews.com)- Enveric Biosciences (NASDAQ: ENVB ) reported, this morning, that it agreed to sell one of its cancer-related patent portfolios for an undisclosed amount, while it plans to continue to focus and invest in the dev...
Enveric continues focused investment advancing novel neuroplastogenic molecules for the treatment of mental health disorders Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuropl...
Novel compounds protected under Enveric’s intellectual property portfolio provide potential licensing opportunities and non-dilutive revenue streams. Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to ...
2024-02-12 12:13:32 ET More on ATAI, COMPASS Pathways, etc. Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
2024-01-23 12:48:13 ET Gainers: Rail Vision Ltd ( RVSN ) +274% . FaZe Holdings ( FAZE ) +100% . Nuvve Holding Corp NVVE +50% . Ensysce Biosciences ENSC +48% . Turnstone Biologics Corp ( TSBX ) +41% . Rumble ( RUM ) +38% . ...
2024-01-11 16:53:41 ET More on Enveric Biosciences Enveric stock jumps 13% on pipeline update Seeking Alpha’s Quant Rating on Enveric Biosciences Historical earnings data for Enveric Biosciences Financial information for Enveric Biosciences For...
Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ther...
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced it has entered into agreemen...
2023-12-28 09:51:28 ET More on Enveric Biosciences Seeking Alpha’s Quant Rating on Enveric Biosciences Historical earnings data for Enveric Biosciences Financial information for Enveric Biosciences For further details see: Enveric stock jumps 13% o...
Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ther...
News, Short Squeeze, Breakout and More Instantly...
Enveric Biosciences Inc Com Company Name:
ENVB Stock Symbol:
NASDAQ Market:
Revealed seven classes of promising novel drug candidates discovered using Enveric’s Psybrary™ and PsyAI™ drug discovery and artificial intelligence (AI) platforms Launched business development campaign that resulted in the execution of seven non-binding term sheets w...
Psychedelics biotech firm, Enveric Biosciences (NASDAQ:ENVB) has signed a non-binding term sheet to out-license a class of Novel Psilocin Prodru...
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology com...